APA (7th ed.) Citation

Yamamoto, S., Sato, I., Fujii, M., Kakimoto, M., Honma, K., Kirihara, S., . . . Watanabe, S. (2023). Therapeutic effect of ouabagenin, a novel liver X receptor agonist, on atherosclerosis in nonalcoholic steatohepatitis in SHRSP5/Dmcr rat model. Canadian Journal of Physiology & Pharmacology, 101(9), 455. https://doi.org/10.1139/cjpp-2022-0532

Chicago Style (17th ed.) Citation

Yamamoto, Shusei, et al. "Therapeutic Effect of Ouabagenin, a Novel Liver X Receptor Agonist, on Atherosclerosis in Nonalcoholic Steatohepatitis in SHRSP5/Dmcr Rat Model." Canadian Journal of Physiology & Pharmacology 101, no. 9 (2023): 455. https://doi.org/10.1139/cjpp-2022-0532.

MLA (9th ed.) Citation

Yamamoto, Shusei, et al. "Therapeutic Effect of Ouabagenin, a Novel Liver X Receptor Agonist, on Atherosclerosis in Nonalcoholic Steatohepatitis in SHRSP5/Dmcr Rat Model." Canadian Journal of Physiology & Pharmacology, vol. 101, no. 9, 2023, p. 455, https://doi.org/10.1139/cjpp-2022-0532.